IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $14,762,000 | -28.3% | 533,301 | -52.9% | 1.98% | -48.1% |
| Q3 2019 | $20,586,000 | -46.2% | 1,131,101 | -27.5% | 3.81% | -54.2% |
| Q2 2019 | $38,234,000 | -7.1% | 1,559,299 | -64.0% | 8.32% | -2.1% |
| Q1 2019 | $41,162,000 | -21.8% | 4,328,303 | -27.3% | 8.50% | +22.7% |
| Q4 2018 | $52,668,000 | -4.3% | 5,951,153 | +21.6% | 6.92% | -14.5% |
| Q3 2018 | $55,062,000 | +3.1% | 4,894,361 | +17.3% | 8.10% | -3.7% |
| Q2 2018 | $53,429,000 | +246.3% | 4,174,105 | +357.2% | 8.41% | +249.9% |
| Q1 2018 | $15,429,000 | -17.6% | 912,987 | -61.0% | 2.40% | -21.5% |
| Q4 2017 | $18,725,000 | -2.9% | 2,340,611 | -5.9% | 3.06% | +7.3% |
| Q3 2017 | $19,279,000 | +15.2% | 2,487,622 | +9.3% | 2.85% | +40.4% |
| Q2 2017 | $16,731,000 | – | 2,276,359 | – | 2.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |